Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca 2+ in pancreatic B-cells

By Garcia-Barrado M.-J.   Jonas J.-C.   Gilon P.   Henquin J.-C.  

European Journal of Pharmacology, Vol. 298, Iss. 3, 1996-03 ,pp. : 279-286

Elsevier

Access to resources Recommend Favorite

Belimumab: Anti-BLyS Monoclonal Antibody; Benlysta™; BmAb; LymphoStat-B

By  

Drugs in R&D, Vol. 10, Iss. 1, 2010-05 ,pp. : 55-65

Adis International

Access to resources Recommend Favorite

Belimumab: Anti-BLyS Human Monoclonal Antibody, Anti-BLyS Monoclonal Antibody, BmAb, Human Monoclonal Antibody to B-Lymphocyte Stimulator

By Adis International Limited  

Drugs in R&D, Vol. 9, Iss. 3, 2008-01 ,pp. : 197-202

Adis International

Access to resources Recommend Favorite

Belimumab: In Systemic Lupus Erythematosus

By Burness Celeste B.   McCormack Paul L.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2435-2444

Adis International

Access to resources Recommend Favorite

Reprogramming of B Cells into Regulatory Cells with Engineered Fusokines

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 3, 2012-06 ,pp. : 248-254

Bentham Science Publishers

Access to resources Recommend Favorite